The Food and Drug Administration approved Myqorzo, a once-daily pill containing the active ingredient aficamten, for adults ...

Artificial intelligence is becoming an increasingly powerful tool in medicine, helping doctors detect disease earlier and ...

Heart disease remains the leading cause of death around the world. One of the biggest reasons is a condition called ...

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

Sarah Urbut, MD, Ph.D., of the Mass General Brigham Heart and Vascular Institute, is the lead author of a paper published in ...

A new report states that older adults using GLP-1 drugs may have a higher risk of loss of muscle mass, malnutrition, ...

For an eighth consecutive year, SSM Health St. Agnes Hospital has received the American Heart Association’s Get With The ...

CKD is common, especially in older adults, and can result from many different underlying conditions, especially diabetes.

A gum disease bacterium may contribute to aortic valve calcification through inflammation, according to preliminary human ...

Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

The FDA approved a first-of-its-kind pill that can drastically reduce cholesterol in a way previously only available with ...